Company Albireo Pharma, Inc.
Equities
ALBO
US01345P1066
Biotechnology & Medical Research
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 03-12-07 | |
President | 57 | 23-03-01 | |
Joan Connolly
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-12 |
Paul Streck
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-12-18 |
Heather White
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Alan Sokaler
BRD | Director/Board Member | - | - |
Corporate Secretary | - | 23-03-01 | |
Michelle Graham
HRO | Human Resources Officer | 57 | 19-11-03 |
Muffy Carter
LAW | General Counsel | 71 | 16-11-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 23-03-01 | |
Director/Board Member | 62 | 23-03-01 | |
Alan Sokaler
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,709,043 | 18,650,831 ( 90.06 %) | 7,760 ( 0.0375 %) | 90.06 % |
Company contact information
Albireo Pharma, Inc.
53 State Street 19th Floor
02109, Boston
+857 254 5555
![address Albireo Pharma, Inc.(ALBO)](https://cdn.zonebourse.com/static/address/31816183.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+18.00% | 122B | |
+19.23% | 112B | |
-24.13% | 19.33B | |
-18.45% | 16.17B | |
-19.11% | 15.6B | |
-49.33% | 14.65B | |
+57.49% | 14.34B | |
+6.72% | 14B | |
+126.27% | 11.29B |